Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-24-048293
Filing Date
2024-11-18
Accepted
2024-11-18 17:10:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 spyretherapeutics-prelimin.htm 424B5 458600
2 spyrelogo1a1a.jpg GRAPHIC 27568
3 spyrelogo1a2a.jpg GRAPHIC 4756
4 spyrelogo1aa.jpg GRAPHIC 44434
  Complete submission text file 0001628280-24-048293.txt   565845
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-281975 | Film No.: 241472369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)